Magnetite-Enhanced Hemostatic Powder for Controlled Wound Application

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing hemostasis powders face challenges in delivering and controlling the application on non-flat wound surfaces, particularly around catheter lines, where powders tend to spill over due to their non-magnetic nature and lack of adherence, leading to incomplete blood flow cessation.

Innovation Solution

Incorporating Magnetite into a potassium ferrate/strong acid cation exchange resin mixture creates a magnetically attachable and effective hemostatic powder that can be uniformly distributed and held in place, enhancing delivery and control by forming a strong blood seal without compromising the seal's strength.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If hemostasis powder is applied to non-flat wound surfaces, then blood flow cessation is achieved, but the powder spills over and loses adherence

Engineering Contradiction:
Improveblood flow cessationVSAvoidpowder application control
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

Magnetite particles are introduced as an intermediary magnetic component within the hemostasis powder formulation. These particles enable magnetic interaction between the powder and an external magnet, allowing controlled placement and adherence to wound surfaces without spilling. The magnetite acts as a mediator that translates magnetic field influence into mechanical retention of the powder at the target site.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces traditional mechanical application methods (sprinkling, pouring) with magnetic field-based control. Instead of relying on gravity and manual precision to keep powder in place, a magnetic field is used to actively hold and position the magnetized powder on non-flat wound surfaces, including around catheter lines, providing superior adherence and control.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Ease of operation

If Magnetite is added to potassium ferrate/resin mixture, then delivery and control of powder is improved, but the composition complexity increases

Engineering Contradiction:
Improvepowder delivery controlVSAvoidcomposition complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The hemostasis powder is formulated as a composite material containing three key components: potassium ferrate (hemostatic agent), strong acid cation exchange resin (structural matrix), and magnetite particles (magnetic control component). This composite structure integrates multiple functions—hemostasis, structural integrity, and magnetic addressability—into a single unified formulation that simplifies application while enhancing performance.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The magnetite-enhanced powder composition serves multiple functions simultaneously: it provides hemostatic activity through potassium ferrate, maintains structural integrity via the resin matrix, enables magnetic-controlled delivery and positioning, and offers antimicrobial protection. This multi-functionality reduces the need for separate application steps or additional devices, offsetting the increased compositional complexity with operational simplicity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If hemostasis powder is used around catheter lines, then blood flow cessation is achieved, but powder spills over the catheter

Engineering Contradiction:
Improveblood flow cessationVSAvoidpowder spillage
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

Magnetite particles serve as a magnetic intermediary that enables precise control of powder placement around catheter lines. The external magnet creates a magnetic field that confines the magnetized powder to the desired area, preventing spillage over the catheter while ensuring adequate coverage for hemostasis. This magnetic mediation allows the powder to conform to complex geometries including catheter surfaces.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the magnetic parameter of the powder by incorporating magnetite, transforming it from a non-magnetic material that cannot be controlled near catheters to a magnetically addressable formulation. This parameter change enables new application modes where the powder can be held in place by magnetic fields, preventing spillage and improving delivery control in the presence of catheter lines and other medical devices.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Magnetite-enhanced powder demonstrates improved delivery and control, maintaining seal strength and providing broad-spectrum antimicrobial activity, reducing hospital-acquired infections and allowing for extended dressing changes, while being easily applied and held in place on uneven surfaces.

Implementation Method 1

a magnetically attachable and effective hemostatic powder that can be uniformly distributed and held in place

Methodology Applied
Scientific EffectMagnetism: Magnetism

Implementation Method 2

an anhydrous salt ferrate compound preferably combined with an effective amount of an insoluble cation exchange material

Methodology Applied
Scientific EffectCation exchange: Ion Exchange

Data Source

PatentUS8979726B2Hemostasis composition with magnetite
Publication Date: 2015.03.17 BIOLIFE DELAWARE LLC
  • US8979726B2 patent drawing
  • US8979726B2 patent drawing
  • US8979726B2 patent drawing

AI summary

A composition and method of arresting the flow of blood from a bleeding wound. The composition preferably includes an anhydrous salt ferrate compound preferably combined with an effective amount of an insoluble cation exchange material and an effective amount of anhydrous Magnetite mixed uniformly together. Povidone iodine may be added for enhanced antimicrobial properties. In the method, a quantity of the composition is magnetically attached to a surface of a magnet, after which the powderous mixture is applied to the wound by pressing the surface covered with the powderous compound against the wound for a time sufficient to clot the blood to arrest substantial further blood flow from the wound.